Lataa...
Cardiotoxicity of anthracycline therapy: current perspectives
Anthracyclines, especially doxorubicin and daunorubicin, are the drugs of first choice in the treatment of patients with hematologic malignancies, soft-tissue sarcomas, and solid tumors. Unfortunately, the use of anthracyclines is limited by their dose-dependent and cumulative cardiotoxicity. The mo...
Tallennettuna:
| Julkaisussa: | Arch Med Sci |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Termedia Publishing House
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4848373/ https://ncbi.nlm.nih.gov/pubmed/27186191 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/aoms.2016.59270 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|